Merck says COVID-19 pill cuts risks in half, will seek emergency authorization | The Hill: Healthcare Policy

Pharmaceutical company Merck on Friday said it will seek an emergency authorization for their oral antiviral COVID-19 treatment after the medicine was shown to reduce the risk of hospitalization by 50 percent during clinical trials.An analysis of...